DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 8Accord healthcare
03 2Accure Labs
04 1Apotex Inc
05 1Assia Chemical Industries Ltd
06 1Aurobindo Pharma Limited
07 1Auxilia Pharma Oü
08 2Bluepharma
09 12Boucher & Muir
10 1Central Procurement & Supplies Unit
11 1Eugia Pharma
12 2Eurolab
13 2GSK
14 4Glenmark Pharmaceuticals
15 2Intas Pharmaceuticals
16 2Laboratorio Eczane Pharma
17 1Lotus Support Services S.R.L.
18 4Newbury Pharmaceuticals Ab
19 27Novartis Pharmaceuticals Corporation
20 2Novartis South Africa (Pty) Ltd
21 1Novugen
22 2PharOS Ltd
23 2Pharmacare Premium
24 1Pharmascience Inc.
25 2Pinnacle Life Science
26 2Pluviaendo
27 6STADA Arzneimittel
28 2Sakar Healthcare
29 4Sandoz B2B
30 2Spirig Healthcare
31 1Sun Pharmaceutical Industries Limited
32 3Teva Pharmaceutical Industries
33 2TherDose Pharma
34 3Torrent Pharmaceuticals Limited
35 4Viatris
36 6Zentiva
01 5FCT
02 56Film Coated Tablet
03 11Film-Coated Tablet
04 2Oral
05 5TABLET
06 8TABLET;ORAL
07 6Tablet
08 4Tablets
09 24Blank
01 6Allowed
02 12Approved
03 7Authorised
04 8Authorized
05 1DISCN
06 5Generic
07 2Marketed
08 2Originator
09 28Prescription
10 7RX
11 1Withdrawn
12 42Blank
01 1EUGIA-PAZOPANIB
02 6PAZOPANIB HYDROCHLORIDE
03 1PAZOTEV 400
04 1PMS-PAZOPANIB
05 2Pazopane
06 2Pazopanib
07 1Pazopanib 200 Eurolab
08 1Pazopanib 400 Eurolab
09 12Pazopanib ADVZ
10 6Pazopanib Accord
11 1Pazopanib Auxilia
12 4Pazopanib Glenmark
13 2Pazopanib Hydrochloride
14 1Pazopanib Lotus
15 2Pazopanib Newbury
16 2Pazopanib Pharmacare
17 2Pazopanib Pharos
18 3Pazopanib Sandoz
19 1Pazopanib Sandoz film-coated tablets
20 2Pazopanib Spirig HC
21 4Pazopanib Stada
22 2Pazopanib Teva
23 2Pazopanib Viatris
24 4Pazopanib Zentiva
25 2Pazopanib "Accord"
26 2Pazopanib "Glenmark"
27 2Pazopanib "Newbury"
28 2Pazopanib "Stada"
29 2Pazopanib "Viatris"
30 2Pazopanib "Zentiva"
31 1Pyzypi
32 3VOTRIENT
33 24Votrient
34 1Votrient 200 mg
35 1Votrient 400 mg
36 14Blank
01 2Argentina
02 24Australia
03 3Canada
04 14Denmark
05 11Estonia
06 14India
07 8Malta
08 2Norway
09 2Portugal
10 5South Africa
11 8Spain
12 12Sweden
13 6Switzerland
14 2Turkey
15 8USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Pazopanib
Dosage Form : Oral
Dosage Strength : 200 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Pazopanib
Dosage Form : Oral
Dosage Strength : 400 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2023-10-19
Application Number : 217713
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2023-10-19
Application Number : 217517
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2024-12-04
Application Number : 219034
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Portugal
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Portugal
Regulatory Info :
Registration Country : Portugal
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Portugal
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : Argentina
Brand Name : Pazopane
Dosage Form : Tablet
Dosage Strength : 200MG
Packaging : 30 Tabs
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Argentina
Regulatory Info :
Registration Country : Argentina
Brand Name : Pazopane
Dosage Form : Tablet
Dosage Strength : 400MG
Packaging : 30 Tabs
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Argentina
Regulatory Info : RX
Registration Country : USA
Brand Name : VOTRIENT
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2009-10-19
Application Number : 22465
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VOTRIENT
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2009-10-19
Application Number : 22465
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2024-04-23
Application Number : 218231
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2023-10-19
Application Number : 215837
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PAZOPANIB HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 400MG BASE
Packaging :
Approval Date : 2025-09-04
Application Number : 219922
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
